148 related articles for article (PubMed ID: 19997697)
1. Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema.
Laimer M; Namberger K; Massone C; Koller J; Emberger M; Pleyer L; Hintner H; Greil R
Acta Derm Venereol; 2009 Nov; 89(6):631-5. PubMed ID: 19997697
[TBL] [Abstract][Full Text] [Related]
2. Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema.
Bos R; de Waal EG; Kuiper H; Hazenberg BP; Vellenga E
Rheumatology (Oxford); 2011 Oct; 50(10):1925-6. PubMed ID: 21719421
[No Abstract] [Full Text] [Related]
3. Scleromyxoedema due to a plasma cell neoplasm: rapid remission with bortezomib, thalidomide and dexamethasone.
Yeung CK; Loong F; Kwong YL
Br J Haematol; 2012 May; 157(4):411. PubMed ID: 22429092
[No Abstract] [Full Text] [Related]
4. [Response to thalidomide in scleromyxedema].
Pascualini MF; Caballero Escuti G; Valente E; Kurpis M; Ruiz Lascano A
Medicina (B Aires); 2013; 73(3):252-4. PubMed ID: 23732202
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of intravenous immunoglobulin in the treatment of scleromyxoedema].
Sillard L; Passeron T; Cardot-Leccia N; Perrin C; Lacour JP; Ortonne JP
Ann Dermatol Venereol; 2010 Jan; 137(1):48-52. PubMed ID: 20110069
[TBL] [Abstract][Full Text] [Related]
6. Scleromyxedema without paraproteinemia.
Abarzúa AA; Giesen LF; Sandoval MO; González SB
Int J Dermatol; 2014 Aug; 53(8):971-4. PubMed ID: 24527753
[TBL] [Abstract][Full Text] [Related]
7. Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature.
Efthimiou P; Blanco M
Semin Arthritis Rheum; 2008 Dec; 38(3):188-94. PubMed ID: 18221985
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of scleromyxedema with oral thalidomide.
Guarenti I; Sebastiani V; Pinto G; de Souza PR; de Almeida H
Int J Dermatol; 2013 May; 52(5):631-2. PubMed ID: 23231733
[No Abstract] [Full Text] [Related]
9. Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.
Manousaridis I; Loeser C; Goerdt S; Hassel JC
Acta Dermatovenerol Alp Pannonica Adriat; 2010 Dec; 19(4):15-9. PubMed ID: 21390475
[TBL] [Abstract][Full Text] [Related]
10. Scleromyxedema: successful treatment with thalidomide in two patients.
Amini-Adle M; Thieulent N; Dalle S; Balme B; Thomas L
Dermatology; 2007; 214(1):58-60. PubMed ID: 17191049
[TBL] [Abstract][Full Text] [Related]
11. Scleromyxedema with monoclonal gammopathy and neurological involvement: recovery from coma after plasmapheresis?
do Prado AD; Schmoeller D; Bisi MC; Piovesan DM; Dias FS; Staub HL
Int J Dermatol; 2012 Aug; 51(8):1013-5. PubMed ID: 21671910
[No Abstract] [Full Text] [Related]
12. Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide.
Peter LM; Ammoury A; Chiavassa-Gandois H; Lamant L; Paul CF
Clin Exp Dermatol; 2008 Aug; 33(5):606-10. PubMed ID: 18477005
[TBL] [Abstract][Full Text] [Related]
13. Scleromyxedema--thalidomide therapy.
Martins A; Paiva Lopes MJ; Tavares Belo R; Rodrigues JC
J Eur Acad Dermatol Venereol; 2008 May; 22(5):622-4. PubMed ID: 18312333
[No Abstract] [Full Text] [Related]
14. Scleromyxoedema with disseminated subcutaneous nodules: rare presentation of an uncommon dermatosis.
Singh S; Kanwar AJ; Saikia UN
Clin Exp Dermatol; 2013 Jan; 38(1):36-9. PubMed ID: 22607617
[TBL] [Abstract][Full Text] [Related]
15. [Clinical characteristics, outcome of scleromyxoedema: a retrospective multicentre study].
Le Moigne M; Mazereeuw-Hautier J; Bonnetblanc JM; Astudillo L; D'Incan M; Bessis D; Thomas L; Debarbieux S; Ammoury A; Lamant L; Paul C
Ann Dermatol Venereol; 2010 Dec; 137(12):782-8. PubMed ID: 21134580
[TBL] [Abstract][Full Text] [Related]
16. [Thalidomide with or without dexamethasone for refractory multiple myeloma].
Boulin M; Blanchet F; Isambert N; Solary E; Solier S; Collin B; Pernot C; Durnet-Archeray MJ
Therapie; 2002; 57(6):524-9. PubMed ID: 12666259
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide-dexamethasone versus interferon-alpha-dexamethasone as maintenance treatment after ThaDD induction for multiple myeloma: a prospective, multicentre, randomised study.
Offidani M; Corvatta L; Polloni C; Piersantelli MN; Gentili S; Galieni P; Visani G; Alesiani F; Catarini M; Brunori M; Samori A; Burattini M; Centurioni R; Ferranti M; Giuliodori L; Candela M; Mele A; Marconi M; Leoni P
Br J Haematol; 2009 Mar; 144(5):653-9. PubMed ID: 19036082
[TBL] [Abstract][Full Text] [Related]
18. Plasma cell-directed therapies in monoclonal gammopathy-associated scleromyxedema.
Mahévas T; Arnulf B; Bouaziz JD; Livideanu CB; Osio A; Servy A; Cribier B; Sassolas B; Jachiet M; Michel L; Aucouturier P; Lipsker D; Frances C; Sbidian E; Rybojad M; Descamps V; D'Incan M; Humbert P; Beylot-Barry M; Passeron T; de Moreuil C; Taha RY; Hermine O; Dupuy A; Barbarot S; Debarbieux S; Carpentier O; Brault F; Schmutz JL; Thomas-Beaulieu D; Modiano P; Zarnitsky C; Lifermann F; Baubion E; Limal N; Le Bras F; Le Moigne M; Tauber M; Talbot A; Prud'homme R; Peltier S; De Masson A; Battistella M; Bagot M; Mékinian A; Fain O
Blood; 2020 Apr; 135(14):1101-1110. PubMed ID: 32027747
[TBL] [Abstract][Full Text] [Related]
19. Scleromyxedema with myopathy was successfully treated by thalidomide.
Wu MY; Hong JB; Yang CC; Hu SL; Liao YH
J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):189-90. PubMed ID: 18435730
[No Abstract] [Full Text] [Related]
20. Advances in oral therapy in the treatment of multiple myeloma.
Doss DS
Clin J Oncol Nurs; 2006 Aug; 10(4):514-20. PubMed ID: 16927905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]